Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer

Long noncoding RNAs (lncRNAs) have been associated with cancer immunity regulation and the tumor microenvironment (TME). However, functions of lncRNAs of tumor-infiltrating B lymphocytes (TIL-Bs) and their clinical significance have not yet been fully elucidated. In the present study, a machine learning-based computational framework is presented for the identification of lncRNA signature of TIL-Bs (named 'TILBlncSig') through integrative analysis of immune, lncRNA and clinical profiles. The TILBlncSig comprising eight lncRNAs (TNRC6C-AS1, WASIR2, GUSBP11, OGFRP1, AC090515.2, PART1, MAFG-DT and LINC01184) was identified from the list of 141 B-cell-specific lncRNAs. The TILBlncSig was capable of distinguishing worse compared with improved survival outcomes across different independent patient datasets and was also independent of other clinical covariates. Functional characterization of TILBlncSig revealed it to be an indicator of infiltration of mononuclear immune cells (i.e. natural killer cells, B-cells and mast cells), and it was associated with hallmarks of cancer, as well as immunosuppressive phenotype. Furthermore, the TILBlncSig revealed predictive value for the survival outcome and immunotherapy response of patients with anti-programmed death-1 (PD-1) therapy and added significant predictive power to current immune checkpoint gene markers. The present study has highlighted the value of the TILBlncSig as an indicator of immune cell infiltration in the TME from a noncoding RNA perspective and strengthened the potential application of lncRNAs as predictive biomarkers of immunotherapy response, which warrants further investigation.

[1]  X. He,et al.  An atlas of infiltrated B-lymphocytes in breast cancer revealed by paired single-cell RNA-sequencing and antigen receptor profiling , 2019, bioRxiv.

[2]  Ming Sun,et al.  LncRNA PART1 modulates toll-like receptor pathways to influence cell proliferation and apoptosis in prostate cancer cells , 2017, Biological chemistry.

[3]  Carolyn J. Brown,et al.  MA24.06 Long Non-Coding Rna Expression Patterns Delineate Infiltrating Immune Cells in the Lung Tumour Microenvironment , 2018, Journal of Thoracic Oncology.

[4]  Keji Zhao,et al.  Expression and regulation of lincRNAs during T cell development and differentiation , 2013, Nature Immunology.

[5]  Stefan Michiels,et al.  Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Elena Butturini,et al.  Tumor Dormancy and Interplay with Hypoxic Tumor Microenvironment , 2019, International journal of molecular sciences.

[7]  D. Larsimont,et al.  Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer. , 2019, JCI insight.

[8]  Mark W. Ball,et al.  Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma , 2018, Science.

[9]  M. Duffy,et al.  Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients. , 2019, Clinical chemistry.

[10]  Z. Trajanoski,et al.  Quantifying tumor-infiltrating immune cells from transcriptomics data , 2018, Cancer Immunology, Immunotherapy.

[11]  S. Yeh,et al.  Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals , 2015, Oncotarget.

[12]  Victor R. Martinez,et al.  In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer. , 2014, Cancer research.

[13]  Siqi Bao,et al.  An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme , 2017, Molecular Neurobiology.

[14]  Oscar Franzén,et al.  PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data , 2019, Database J. Biol. Databases Curation.

[15]  C. Pan,et al.  LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15. , 2019, European review for medical and pharmacological sciences.

[16]  J. Xue,et al.  Immunosuppressive B cells expressing PD-1/PD-L1 in solid tumors: A mini review. , 2019, QJM : monthly journal of the Association of Physicians.

[17]  Jincheng Guo,et al.  A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer. , 2018, Oncology reports.

[18]  J. Rosenblatt,et al.  B cell regulation of the anti-tumor response and role in carcinogenesis , 2016, Journal of Immunotherapy for Cancer.

[19]  Rui Li,et al.  Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers , 2019, Journal of Translational Medicine.

[20]  K. Zou,et al.  Silencing long noncoding RNA OGFRP1 inhibits the proliferation and migration of cervical carcinoma cells , 2019, Cell biochemistry and function.

[21]  F. Cakalagaoglu,et al.  Association of mast cells with microvessel density in urothelial carcinomas of the urinary bladder. , 2012, Annals of diagnostic pathology.

[22]  Chao Cheng,et al.  A B cell-derived gene expression signature associates with an immunologically active tumor microenvironment and response to immune checkpoint blockade therapy , 2018, Oncoimmunology.

[23]  L. Notarangelo,et al.  B cell-intrinsic requirement for STK4 in humoral immunity in mice and human subjects. , 2019, The Journal of allergy and clinical immunology.

[24]  Shao-Gang Ma,et al.  Suppression of long non‐coding RNA TNRC6C‐AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway , 2019, Cell proliferation.

[25]  B. Nelson,et al.  Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer , 2018, Clinical Cancer Research.

[26]  Siqi Bao,et al.  Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma , 2017, Molecular Cancer.

[27]  L. Pease,et al.  Integrative Genome-Wide Analysis of Long Noncoding RNAs in Diverse Immune Cell Types of Melanoma Patients. , 2018, Cancer research.

[28]  Nasir M. Rajpoot,et al.  A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma , 2019, Scientific Reports.

[29]  Zicheng Zhang,et al.  Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer , 2020, Briefings Bioinform..

[30]  T. Chan,et al.  The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy , 2019, Nature Reviews Cancer.

[31]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[32]  Pornpimol Charoentong,et al.  Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.

[33]  yang-xin fu,et al.  PD-1 Shapes B Cells as Evildoers in the Tumor Microenvironment. , 2016, Cancer discovery.

[34]  J. Cui,et al.  The Role of Tumor-Infiltrating B Cells in Tumor Immunity , 2019 .

[35]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[36]  Giorgos Borboudakis,et al.  Forward-Backward Selection with Early Dropping , 2017, J. Mach. Learn. Res..

[37]  Yinshi Zheng,et al.  LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis. , 2019, European journal of pharmacology.

[38]  Congcong Yan,et al.  Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer , 2020, Journal for ImmunoTherapy of Cancer.

[39]  Howard Y. Chang,et al.  Gene regulation in the immune system by long noncoding RNAs , 2017, Nature Immunology.

[40]  Zhenhua Xie,et al.  Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852 , 2019, Experimental and therapeutic medicine.

[41]  N. Jonjić,et al.  Impact of NK Cell Count on Bladder Cancer Recurrence , 2014, Urologia.

[42]  Jun Liu,et al.  Functional analysis of lncRNAs based on competitive endogenous RNA in tongue squamous cell carcinoma , 2019, PeerJ.

[43]  Nasser K. Altorki,et al.  The lung microenvironment: an important regulator of tumour growth and metastasis , 2018, Nature Reviews Cancer.

[44]  Haoyuan Wang,et al.  Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference , 2016, Oncotarget.

[45]  A. Valencia,et al.  The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies , 2015, BMC Genomics.

[46]  S. Yeh,et al.  Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals , 2015, Oncotarget.

[47]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[48]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[49]  Si-Si Wang,et al.  Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer , 2018, Cellular & Molecular Immunology.

[50]  J. Warner,et al.  Improved prognosis and increased tumor infiltrating lymphocytes in small cell lung cancer patients with neurologic paraneoplastic syndromes. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[51]  M. Mathieu,et al.  Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[52]  Franziska Michor,et al.  Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer , 2012, Clinical Cancer Research.

[53]  A. Fatica,et al.  Long non-coding RNAs: new players in cell differentiation and development , 2013, Nature Reviews Genetics.

[54]  Xiaojie Wang,et al.  An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer. , 2019, Annals of clinical and laboratory science.

[55]  Charles M. Perou,et al.  Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer , 2014, Clinical Cancer Research.

[56]  M. Marconi,et al.  LincRNA landscape in human lymphocytes highlights regulation of T cell differentiation by linc-MAF-4 , 2014, Nature Immunology.

[57]  Daniel R. Caffrey,et al.  Immunobiology of Long Noncoding RNAs. , 2017, Annual review of immunology.

[58]  L. Xerri,et al.  PD-1 is a novel regulator of human B-cell activation. , 2013, International Immunology.

[59]  Y. Lotan,et al.  Bladder cancer , 2016, The Lancet.

[60]  B Terracini,et al.  Malignant mesothelioma of the pleura: interobserver variability. , 1995, Journal of clinical pathology.

[61]  M. Knowles,et al.  ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer , 2019, Scientific Reports.

[62]  J. Bouček,et al.  Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells , 2019, Journal of Immunotherapy for Cancer.

[63]  Prachi Gupta,et al.  B Cells as an Immune-Regulatory Signature in Ovarian Cancer , 2019, Cancers.

[64]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[65]  K. Jirström,et al.  Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens , 2019, Oncoimmunology.

[66]  Maite Huarte,et al.  The multidimensional mechanisms of long noncoding RNA function , 2017, Genome Biology.

[67]  C. Amos,et al.  Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy , 2018, Oncoimmunology.

[68]  M. Disis,et al.  Clinical significance of tumor-infiltrating lymphocytes in breast cancer , 2016, Journal of Immunotherapy for Cancer.

[69]  Chengming Sun,et al.  Down‐regulation of lncRNA OGFRP1 induces autophagy and growth inhibition by AKT/mTOR signaling pathway in HCAECs , 2018, Cell biology international.

[70]  J. Wang,et al.  LncRNA MAFG‐AS1 facilitates the migration and invasion of NSCLC cell via sponging miR‐339‐5p from MMP15 , 2019, Cell biology international.

[71]  Q. Fu,et al.  Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis , 2019, Oncoimmunology.